Eibai Lee
Impact in
- Neurology top 10%
- Neuroinflammation and Neurodegeneration Mechanisms
-
- Cell death mechanisms and regulation
- Mitochondrial Function and Pathology
Papers in
-
- Cell death mechanisms and regulation 8
- Natural product bioactivities and synthesis 6
- RNA Interference and Gene Delivery 4
- Immunology 12
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 10
- Co-authors
- Akemichi Baba (12 shared papers)Toshio Matsuda (12 shared papers)Kimio Kariya (15 shared papers)Riyo Enomoto (22 shared papers)Kazuhiro Takuma (10 shared papers)Kōichi Mori (9 shared papers)Aiko Yamauchi (9 shared papers)Hiroteru Sayo (6 shared papers)
- Journals
- Annals of the New York Academy of Sciences (6 papers)Biochemical Pharmacology (5 papers)IUBMB Life (4 papers)European Journal of Pharmacology (3 papers)Biological and Pharmaceutical Bulletin (2 papers)
- Partner nations
- JapanCanadaNetherlands
In The Last Decade
Eibai Lee
54 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 98
- Neurology 80
- Molecular Biology 590
- Pharmacology 136
- Toxicology 27
- Biochemistry 55
Countries citing papers authored by Eibai Lee
This map shows the geographic impact of Eibai Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eibai Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eibai Lee more than expected).
Fields of papers citing papers by Eibai Lee
This network shows the impact of papers produced by Eibai Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eibai Lee. The network helps show where Eibai Lee may publish in the future.
Co-authors
The 25 scholars most cited alongside Eibai Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 130 | |
| 2 | 1999 | 64 | |
| 3 | 1988 | 59 | |
| 4 | 1990 | 49 | |
| 5 | 1996 | 46 | |
| 6 | 2009 | 40 | |
| 7 | Overexpression of constitutive signal transducer and activator of transcription 3 mRNA in cisplatin-resistant human non-small cell lung cancer cells. | 2005 | 40 |
| 8 | 2010 | 39 | |
| 9 | 2005 | 35 | |
| 10 | 2000 | 33 | |
| 11 | 1978 | 32 | |
| 12 | 1987 | 32 | |
| 13 | 2002 | 31 | |
| 14 | 2007 | 30 | |
| 15 | 1982 | 28 | |
| 16 | 2002 | 24 | |
| 17 | 2002 | 22 | |
| 18 | 2006 | 22 | |
| 19 | 2007 | 20 | |
| 20 | 1988 | 19 |
About Eibai Lee
Eibai Lee is a scholar working on Molecular Biology, Immunology, Pharmacology, Physiology and Neurology, having authored 54 papers that have together received 1.1k indexed citations. Recurring topics across this work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (10 papers), Cell death mechanisms and regulation (8 papers), Natural product bioactivities and synthesis (6 papers), Neuroinflammation and Neurodegeneration Mechanisms (5 papers), Nitric Oxide and Endothelin Effects (5 papers), Flavonoids in Medical Research (5 papers), RNA Interference and Gene Delivery (4 papers) and Phytochemistry and Biological Activities (3 papers). The work is most often cited by research in Neurology (80 citations), Molecular Biology (590 citations), Pharmacology (136 citations), Toxicology (27 citations) and Biochemistry (55 citations). Eibai Lee has collaborated with scholars based in Japan, Canada and Netherlands. Frequent co-authors include Akemichi Baba, Toshio Matsuda, Kimio Kariya, Riyo Enomoto, Kazuhiro Takuma, Kōichi Mori, Aiko Yamauchi, Hiroteru Sayo, Heitaroh Iwata and Masaaki Hirouchi. Their work appears in journals such as Annals of the New York Academy of Sciences, Biochemical Pharmacology, IUBMB Life, European Journal of Pharmacology and Biological and Pharmaceutical Bulletin.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.